European Position Statement on Diagnosis, and Treatment of Meniere's Disease

J Int Adv Otol. 2018 Aug;14(2):317-321. doi: 10.5152/iao.2018.140818.


Meniere Disease keeps challenges in its diagnosis and treatment since was defined by Prosper Meniere at the beginning of 19th Century. Several classifications and definition were made until now and speculations still exist on its etiology. As the etiology remains speculative the treatment models remain in discussion also. The European Academy of Otology and Neurotology Vertigo Guidelines Study Group intended to work on the diagnosis and treatment of Meniere's disease and created the European Positional Statement Document also by resuming the consensus studies on it. The new techniques on diagnosis are emphasized as well as the treatment models for each stage of the disease are clarified by disregarding the dilemmas on its treatment. The conservative, noninvasive and invasive therapeutic models are highlighted.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Betahistine / therapeutic use
  • Consensus
  • Conservative Treatment / methods
  • Denervation / methods
  • Diuretics / therapeutic use
  • Endolymphatic Sac / surgery
  • European Union
  • Gentamicins / administration & dosage
  • Gentamicins / therapeutic use
  • Hearing Loss, Sensorineural / diagnosis
  • Hearing Loss, Sensorineural / etiology
  • Histamine Agonists / therapeutic use
  • Humans
  • Injection, Intratympanic
  • Meniere Disease / diagnosis*
  • Meniere Disease / drug therapy*
  • Meniere Disease / epidemiology
  • Meniere Disease / surgery*
  • Neurotology / organization & administration*
  • Otolaryngology / organization & administration*
  • Practice Guidelines as Topic
  • Steroids / therapeutic use
  • Vestibular Evoked Myogenic Potentials / physiology
  • Vestibular Nerve / surgery
  • Vestibule, Labyrinth / surgery


  • Anti-Bacterial Agents
  • Diuretics
  • Gentamicins
  • Histamine Agonists
  • Steroids
  • Betahistine